Comparing the ICERs in medicine reimbursement submissions to NICE and PBAC—does the presence of an explicit threshold affect the ICER proposed?

8 August 2018 - The English NICE and the Australian PBAC require evidence that a new medicine represents value for money ...

Read more →

PBAC post-market reviews of chronic obstructive pulmonary disease medicines and ezetimibe

5 August 2016 - The public submission process is now closed. ...

Read more →

Expanded PBS Safety Net early supply arrangements apply from 1 January 2016

4 January 2016 - Measures announced as part of the PBS Access and Sustainability package include expanding Safety Net early supply ...

Read more →

Meet the health crusader saving lives with cheap drugs

20 August 2015 - A Tasmanian man with hepatitis C is taking on a global pharmaceutical company for what he says ...

Read more →